PEN vs. PHG, ZBH, SOLV, SNN, GKOS, STVN, BLCO, INSP, NARI, and PRCT
Should you be buying Penumbra stock or one of its competitors? The main competitors of Penumbra include Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Solventum (SOLV), Smith & Nephew (SNN), Glaukos (GKOS), Stevanato Group (STVN), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Inari Medical (NARI), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical equipment" industry.
Penumbra vs.
Koninklijke Philips (NYSE:PHG) and Penumbra (NYSE:PEN) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation, profitability and media sentiment.
Penumbra has a consensus target price of $258.00, indicating a potential downside of 2.30%. Given Penumbra's stronger consensus rating and higher possible upside, analysts plainly believe Penumbra is more favorable than Koninklijke Philips.
Penumbra has lower revenue, but higher earnings than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.
In the previous week, Koninklijke Philips had 3 more articles in the media than Penumbra. MarketBeat recorded 6 mentions for Koninklijke Philips and 3 mentions for Penumbra. Penumbra's average media sentiment score of 0.50 beat Koninklijke Philips' score of 0.24 indicating that Penumbra is being referred to more favorably in the news media.
Penumbra has a net margin of 2.97% compared to Koninklijke Philips' net margin of -1.83%. Koninklijke Philips' return on equity of 10.11% beat Penumbra's return on equity.
Penumbra received 444 more outperform votes than Koninklijke Philips when rated by MarketBeat users. Likewise, 80.29% of users gave Penumbra an outperform vote while only 56.56% of users gave Koninklijke Philips an outperform vote.
Koninklijke Philips has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.52, indicating that its stock price is 48% less volatile than the S&P 500.
13.7% of Koninklijke Philips shares are owned by institutional investors. Comparatively, 88.9% of Penumbra shares are owned by institutional investors. 5.0% of Penumbra shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Summary
Penumbra beats Koninklijke Philips on 15 of the 19 factors compared between the two stocks.
Get Penumbra News Delivered to You Automatically
Sign up to receive the latest news and ratings for PEN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Penumbra Competitors List
Related Companies and Tools
This page (NYSE:PEN) was last updated on 1/20/2025 by MarketBeat.com Staff
Free PEN Stock Alerts